Daniel Schwarz

Inga fler pågående positioner

Finance

Consumer Services

Commercial Services

Profil

Daniel Schwarz worked as a Senior Auditor at KPMG from 2004 to 2007.
From 2018 to 2021, Mr. Schwarz was COO & CFO at Steelhead Capital Management LLC.
From 2018 to 2025, Mr. Schwarz was COO & CFO at BIOS Capital Management LP.
Mr. Schwarz graduated from Texas A&M University in 2003.

Tidigare kända positioner av Daniel Schwarz

Företag	Position	Slut
BIOS Capital Management LP BIOS Capital Management LP Investment ManagersFinance BIOS Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and medical device sectors. It provides financing for early and later stage capital requirements.	Finansdirektör/CFO	2025-04-01
Steelhead Capital Management LLC Steelhead Capital Management LLC Investment ManagersFinance Acts as an alternative investment manager	Finansdirektör/CFO	2021-06-01
KPMG KPMG Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax,investment advice and financial services	Comptroller/Controller/Revisor	2007-03-31

Se detaljerna i Daniel Schwarzs erfarenhet

Daniel Schwarzs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Daniel Schwarzs erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	4
Texas A&M University Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
KPMG KPMG Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax,investment advice and financial services	Commercial Services
Steelhead Capital Management LLC Steelhead Capital Management LLC Investment ManagersFinance Acts as an alternative investment manager	Finance
BIOS Capital Management LP BIOS Capital Management LP Investment ManagersFinance BIOS Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and medical device sectors. It provides financing for early and later stage capital requirements.	Finance